Cargando…
ATRX is a regulator of therapy induced senescence in human cells
Senescence is a state of stable cell cycle exit with important implications for development and disease. Here, we demonstrate that the chromatin remodeling enzyme ATRX is required for therapy-induced senescence. ATRX accumulates in nuclear foci and is required for therapy-induced senescence in multi...
Autores principales: | Kovatcheva, Marta, Liao, Will, Klein, Mary E., Robine, Nicolas, Geiger, Heather, Crago, Aimee M., Dickson, Mark A., Tap, William D., Singer, Samuel, Koff, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577318/ https://www.ncbi.nlm.nih.gov/pubmed/28855512 http://dx.doi.org/10.1038/s41467-017-00540-5 |
Ejemplares similares
-
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition
por: Kovatcheva, Marta, et al.
Publicado: (2015) -
Mechanistic understanding of the role of ATRX in senescence provides new insight for combinatorial therapies with CDK4 inhibitors.
por: Kovatcheva, Marta, et al.
Publicado: (2017) -
PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence
por: Klein, Mary E., et al.
Publicado: (2018) -
ATRX guards against aberrant differentiation in mesenchymal progenitor cells
por: Fang, Yan, et al.
Publicado: (2023) -
Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma
por: Fan, Hueng-Chuen, et al.
Publicado: (2019)